News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website


Liquid Biopsy for Detection of Histone H3 Mutations in Pediatric Diffuse Midline Gliomas


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 This will be very useful as we can now detect this mutation without doing a biopsy, so it can be used not only to direct the original treatment but to monitor how well the treatment is working.


Posted on: 04/18/2019

Liquid Biopsy for Detection of Histone H3 Mutations in Pediatric Diffuse Midline Gliomas

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740